{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+Dementia&page=2", "query": { "condition": "Moderate Dementia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+Dementia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T20:51:39.017Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01369225", "title": "Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "AAB-003 (PF-05236812)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 52, "start_date": "2011-07", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2017-03-10", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 15, "location_summary": "Hallandale, Florida • Ocala, Florida • Atlanta, Georgia + 7 more", "locations": [ { "city": "Hallandale", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Ocala", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01369225" }, { "nct_id": "NCT00948909", "title": "Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "ABT-126", "type": "DRUG" }, { "name": "donepezil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 274, "start_date": "2009-10", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2013-01-31", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 3, "location_summary": "Fresno, California • West Palm Beach, Florida • Indianapolis, Indiana", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00948909" }, { "nct_id": "NCT00265148", "title": "Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Rosiglitazone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 80, "start_date": "2004-05-18", "completion_date": "2008-07-10", "has_results": true, "last_update_posted_date": "2020-11-18", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 9, "location_summary": "Litchfield Park, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 6 more", "locations": [ { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00265148" }, { "nct_id": "NCT04491006", "title": "A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer Disease", "Dementia of Alzheimer Type" ], "interventions": [ { "name": "ATH-1017", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LeonaBio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 77, "start_date": "2020-11-23", "completion_date": "2022-05-20", "has_results": true, "last_update_posted_date": "2023-06-12", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 7, "location_summary": "Santa Ana, California • West Palm Beach, Florida • Decatur, Georgia + 4 more", "locations": [ { "city": "Santa Ana", "state": "California" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Albany", "state": "New York" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04491006" }, { "nct_id": "NCT02754830", "title": "A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "LY3303560 - IV", "type": "DRUG" }, { "name": "Saline Solution - IV", "type": "DRUG" }, { "name": "LY3303560 - SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 72, "start_date": "2016-04-25", "completion_date": "2018-07-10", "has_results": true, "last_update_posted_date": "2023-10-13", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 2, "location_summary": "Glendale, California • Baltimore, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02754830" }, { "nct_id": "NCT00988598", "title": "A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "PF-04447943", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 15, "start_date": "2009-10-26", "completion_date": "2010-07-05", "has_results": true, "last_update_posted_date": "2020-11-19", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 3, "location_summary": "Glendale, California • Gainesville, Florida • Hallandale, Florida", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Hallandale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00988598" }, { "nct_id": "NCT01969136", "title": "Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer's Disease", "Dementia" ], "interventions": [ { "name": "Drug: EVP-6124", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "FORUM Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 403, "start_date": "2013-10", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2016-05-03", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 42, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Culver City, California + 39 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Culver City", "state": "California" }, { "city": "Downey", "state": "California" }, { "city": "Los Alamitos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01969136" }, { "nct_id": "NCT05637801", "title": "A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease", "Alzheimer Disease 1", "Alzheimer Disease 2", "Alzheimer Disease 3", "Alzheimer Disease, Early Onset", "Alzheimer Disease, Late Onset", "Alzheimer Disease 9", "Alzheimer Disease 4", "Alzheimer Disease 7", "Alzheimer Disease 17", "Alzheimer's Dementia Late Onset", "Alzheimer Disease 5", "Alzheimer Disease 6", "Alzheimer Disease 8", "Alzheimer Disease 10", "Alzheimer Disease 11", "Alzheimer Disease 12", "Alzheimer Disease 13", "Alzheimer Disease 14", "Alzheimer Disease 15", "Alzheimer Disease 16", "Alzheimer Disease 18", "Alzheimer Disease 19", "Dementia", "Dementia Alzheimers", "Dementia, Mild", "Dementia of Alzheimer Type", "Dementia Moderate", "Dementia Senile", "Mild Cognitive Impairment", "Mild Dementia", "MCI", "Cognitive Impairment", "Cognitive Decline", "Cognitive Impairment, Mild" ], "interventions": [ { "name": "Spectris™ AD - Active", "type": "DEVICE" }, { "name": "Spectris™ AD - Sham", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cognito Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 670, "start_date": "2022-12-13", "completion_date": "2026-07", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 68, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Sun City, Arizona + 62 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05637801" }, { "nct_id": "NCT00428090", "title": "Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Rosiglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 862, "start_date": "2007-02-27", "completion_date": "2008-09-05", "has_results": true, "last_update_posted_date": "2017-05-19", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Los Angeles, California • Newport Beach, California + 34 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Reseda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00428090" }, { "nct_id": "NCT00722046", "title": "Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "PF-04360365 0.1 mg/kg", "type": "BIOLOGICAL" }, { "name": "PF-04360365 0.5 mg/kg", "type": "BIOLOGICAL" }, { "name": "PF-04360365 1 mg/kg", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "PF-04360365 3 mg/kg", "type": "BIOLOGICAL" }, { "name": "PF-04360365 8.5 mg/kg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 198, "start_date": "2008-12-05", "completion_date": "2011-08-16", "has_results": true, "last_update_posted_date": "2022-11-07", "last_synced_at": "2026-06-10T20:51:39.017Z", "location_count": 15, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Miami, Florida + 6 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00722046" } ] }